Clinical Trial Update: A Study of Zigakibart in Adults With IgA Nephropathy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update indicates Zigakibart is being studied in adults with IgA nephropathy and the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iga Nephropathy

Drugs mentioned

• Zigakibart

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: IgA Nephropathy, Immunoglobulin A Nephropathy | Phase 3 | Status: ACTIVE_NOT_RECRUITING